ORGANOCLICK AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.02 SEK | -4.43% |
|
-0.98% | -5.03% |
| Apr. 30 | OrganoClick AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 23 | OrganoWood AB Announces Three-Year Results from the Field Study EN 12037 for Organowood Nowa | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 497.4 | 1,013 | 685.6 | 293.8 | 311.5 | 295.8 | - | - |
| Enterprise Value (EV) 1 | 497.4 | 1,019 | 698.5 | 327.2 | 349.2 | 334.8 | 314.8 | 304.8 |
| P/E ratio | -20.8 x | -42.3 x | -20.6 x | -6.67 x | -19.9 x | -50.3 x | 30.2 x | 16.8 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | - | 10.5 x | 6.23 x | 2.55 x | 2.14 x | 1.87 x | 2.07 x | 1.75 x |
| EV / Revenue | - | 10.6 x | 6.35 x | 2.84 x | 2.39 x | 2.12 x | 2.2 x | 1.8 x |
| EV / EBITDA | - | -229 x | -53.8 x | -174 x | 59.7 x | 18.6 x | 9.54 x | 8.24 x |
| EV / FCF | - | -73.2 x | -13.3 x | -14.6 x | -43.2 x | -41.9 x | 13.1 x | 19.1 x |
| FCF Yield | - | -1.37% | -7.49% | -6.87% | -2.31% | -2.39% | 7.62% | 5.25% |
| Price to Book | - | 18.7 x | 6.86 x | 5 x | 6.99 x | 7.74 x | 6.29 x | 4.51 x |
| Nbr of stocks (in thousands) | 92,113 | 92,113 | 97,950 | 97,950 | 97,950 | 97,950 | - | - |
| Reference price 2 | 5.400 | 11.00 | 7.000 | 3.000 | 3.180 | 3.020 | 3.020 | 3.020 |
| Announcement Date | 4/15/20 | 2/17/21 | 2/18/22 | 2/15/23 | 2/15/24 | - | - | - |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 96.46 | 110.1 | 115 | 145.9 | 158 | 143 | 169 |
| EBITDA 1 | - | -4.46 | -12.99 | -1.882 | 5.85 | 18 | 33 | 37 |
| EBIT 1 | - | -17.1 | -28.59 | -28.5 | -9.23 | 2 | 15 | 24 |
| Operating Margin | - | -17.73% | -25.98% | -24.77% | -6.33% | 1.27% | 10.49% | 14.2% |
| Earnings before Tax (EBT) 1 | - | -19.53 | -31.17 | -41.72 | -14.09 | -5 | 9 | 18 |
| Net income 1 | -20.39 | -23.65 | -32.69 | -44.4 | -15.77 | -6 | 9 | 18 |
| Net margin | - | -24.51% | -29.7% | -38.59% | -10.81% | -3.8% | 6.29% | 10.65% |
| EPS 2 | -0.2600 | -0.2600 | -0.3400 | -0.4500 | -0.1600 | -0.0600 | 0.1000 | 0.1800 |
| Free Cash Flow 1 | - | -13.93 | -52.34 | -22.47 | -8.077 | -8 | 24 | 16 |
| FCF margin | - | -14.44% | -47.55% | -19.53% | -5.54% | -5.06% | 16.78% | 9.47% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | 72.73% | 43.24% |
| FCF Conversion (Net income) | - | - | - | - | - | - | 266.67% | 88.89% |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 4/15/20 | 2/17/21 | 2/18/22 | 2/15/23 | 2/15/24 | - | - | - |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 17.95 | 32.63 | 38.53 | 22.26 | 21.63 | 43.48 | 41.03 | 33.45 | 27.91 | 38.17 | 47 | 40 | 33 |
| EBITDA 1 | -7.65 | 0.069 | -2.436 | -3.478 | 3.962 | - | - | 0.97 | -2.257 | 4.214 | 7 | 6 | 1 |
| EBIT 1 | -11.83 | -4.189 | -6.734 | -7.91 | -9.7 | 0.088 | -0.38 | -2.806 | -6.13 | 0.154 | 3 | 1 | -3 |
| Operating Margin | -65.89% | -12.84% | -17.48% | -35.54% | -44.84% | 0.2% | -0.93% | -8.39% | -21.96% | 0.4% | 6.38% | 2.5% | -9.09% |
| Earnings before Tax (EBT) 1 | -12.42 | -4.825 | -7.513 | -8.72 | -20.66 | -0.958 | -1.714 | -3.899 | -7.517 | -1.534 | 1 | - | -4 |
| Net income 1 | -11.88 | -5.893 | -8.812 | -9.12 | -20.57 | -0.997 | -2.671 | -4.125 | -7.978 | -2.11 | 1 | - | -4 |
| Net margin | -66.21% | -18.06% | -22.87% | -40.98% | -95.11% | -2.29% | -6.51% | -12.33% | -28.59% | -5.53% | 2.13% | - | -12.12% |
| EPS 2 | -0.1200 | -0.0600 | -0.0900 | -0.0900 | -0.2100 | -0.0100 | -0.0300 | -0.0400 | -0.0800 | -0.0200 | 0.0100 | -0.0100 | -0.0500 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 2/18/22 | 5/4/22 | 8/17/22 | 11/10/22 | 2/15/23 | 5/5/23 | 8/17/23 | 11/9/23 | 2/15/24 | 4/30/24 | - | - | - |
1SEK in Million2SEK
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | 6.11 | 12.9 | 33.3 | 37.7 | 39 | 19 | 9 |
| Net Cash position 1 | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | -1.369 x | -0.9927 x | -17.69 x | 6.444 x | 2.167 x | 0.5758 x | 0.2432 x |
| Free Cash Flow 1 | - | -13.9 | -52.3 | -22.5 | -8.08 | -8 | 24 | 16 |
| ROE (net income / shareholders' equity) | - | -35.9% | -38.7% | -55.8% | -30.5% | -15.4% | 22% | 31.5% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share 2 | - | 0.5900 | 1.020 | 0.6000 | 0.4600 | 0.3900 | 0.4800 | 0.6700 |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex 1 | - | 11.2 | 7.47 | 7.93 | 1.77 | 2 | 1 | 5 |
| Capex / Sales | - | 11.65% | 6.79% | 6.89% | 1.21% | 1.27% | 0.7% | 2.96% |
| Announcement Date | 4/15/20 | 2/17/21 | 2/18/22 | 2/15/23 | 2/15/24 | - | - | - |
1SEK in Million2SEK
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
D+
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -5.03% | 28.65M | |
| +17.43% | 65.38B | |
| +0.11% | 47.8B | |
| +16.88% | 40.65B | |
| +23.50% | 26.69B | |
| +12.85% | 19.24B | |
| +4.74% | 17.75B | |
| -22.01% | 16B | |
| -8.95% | 15.37B | |
| +3.47% | 15.23B |
- Stock Market
- Equities
- ORGC Stock
- Financials OrganoClick AB